Effects of rapeseed oil on body composition and glucolipid metabolism in people with obesity and overweight: a systematic review and meta-analysis
Yang JM, Long Y, Ye H, Wu YL, Zhu Q, Zhang JH, Huang H, Zhong YB, Luo Y, Wang MY
European journal of clinical nutrition · 8 citas
Cómo se estudió
- Diseño
- Metaanálisis (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
- Consumo medido con
- No se indica
Quién lo pagó
- Financiación
- Financiación independiente
- Gobierno
- National Natural Science Foundation of China
- Gobierno
- Natural Science Foundation of Jiangxi Province
- Gobierno
- Natural Science Foundation of Jiangxi Province (Jiangxi Province Natural Science Foundation)
- Gobierno
- National Natural Science Foundation of China (National Science Foundation of China)
- Subvenciones
- National Natural Science Foundation of China (82060420); Natural Science Foundation of Jiangxi Province (20212BAB206004)
Según 4 financiadores declarados.
Publicación
- Publicado
- 2023-09-22 · Eur J Clin Nutr · vol. 78 · número 1 · págs. 6–18
- Editorial
- Springer Nature
- Citado
- 10 citas · más que el 58% de estudios similares · 0.6× el promedio de su campo
- Referencias
- 65 trabajos
- Acceso
- De pago
- Áreas de investigación
- Nutritional Studies and Diet · Fatty Acid Research and Health · Obesity, Physical Activity, Diet
- Palabras clave
- Overweight, Medicine, Obesity, Internal medicine, Randomized controlled trial, Crossover study, Apolipoprotein B, Endocrinology, Cholesterol, Placebo
- MeSH
- humans, obesity, apolipoproteins b, body composition, overweight, cholesterol, ldl, rapeseed oil
10 autores
- Jia‐ming Yang🇨🇳Gannan Medical University; First Affiliated Hospital of Gannan Medical University
- Yi Long🇨🇳Gannan Medical University
- Hua Ye🇨🇳Gannan Medical University
- Yanlin Wu🇨🇳Gannan Medical University
- Qiang Zhu🇨🇳First Affiliated Hospital of Gannan Medical University
- Jiahong Zhang🇨🇳First Affiliated Hospital of Gannan Medical University
- Hui Huang🇨🇳First Affiliated Hospital of Gannan Medical University
- Yanbiao Zhong🇨🇳First Affiliated Hospital of Gannan Medical University
- Yun Luo🇨🇳Ganzhou People's Hospital; First Affiliated Hospital of Gannan Medical University
- Maoyuan Wang🇨🇳 · autor de correspondenciaFirst Affiliated Hospital of Gannan Medical University
Resumen
El texto original del estudio, en el idioma en que se publicó.
To investigate the effects of rapeseed oil on body composition, blood glucose and lipid metabolism in people with overweight and obesity compared to other cooking oils. We searched eight databases for randomized controlled studies (including randomized crossover trials). The risk of bias for the included studies was assessed using the Cochrane Risk of Bias 2.0 tool. The Grading of Recommendations Assessment Development and Evaluation (GRADE) criteria were used to evaluate the quality of the outcomes. The methodological quality of the included studies was assessed using the Physiotherapy Evidence Database (PEDro) scale. Sensitivity analysis was used to check the stability of the pooled results. Statistical analysis was carried out using Review Manager 5.3 software. As a result, fifteen randomized controlled studies (including six parallel studies and nine crossover studies) were included in this study. Compared to other edible oils, rapeseed oil significantly reduced low density lipoprotein cholesterol (LDL-C) (MD = -0.14 mmol/L, 95% CI: -0.21, -0.08, I2 = 0%, P 2 = 0%, P = 0.0003), ApoB/ApoA1 (MD = -0.02, 95% CI: -0.04, -0.00, I2 = 0%, P = 0.02) and insulin (MD = -12.45 pmol/L, 95% CI: -19.61, -5.29, I2 = 37%, P = 0.0007) levels, and increased fasting glucose (MD = 0.16 mmol/L, 95% CI: 0.05, 0.27, I2 = 27%, P = 0.003) levels. However, the differences in body weight and body composition between rapeseed oil and control oils were not significant. In a word, rapeseed oil is effective in reducing LDL-C, ApoB and ApoB/ApoA1 levels in people with overweight and obesity, which is helpful in preventing and reducing the risk of atherosclerosis. PROSPERO registration number: CRD42022333436.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.